ENDPOINTS

Emergent sells once-troubled Baltimore site to Syngene

Emergent BioSolutions is selling a manufacturing site in Baltimore — which has a history of contaminated Covid-19 vaccines — for $36.5 million to India-headquartered CDMO Syngene. The facility in the Bayview neighborhood hasn't been operational for at ...

Mar 10, 2025 - 18:29
 0
Emergent sells once-troubled Baltimore site to Syngene
Emergent BioSolutions is selling a manufacturing site in Baltimore — which has a history of contaminated Covid-19 vaccines — for $36.5 million to India-headquartered CDMO Syngene. The facility in the Bayview neighborhood hasn't been operational for at ...
Read More

Tags:

Previous Article

'Amazing' spinning needle proof unlocks a whole new world of maths

Next Article

Why Older People May Not Need to Watch Blood Sugar So Closely

Related Posts

Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers  

Trump’s tariff impact likely ‘minimal’ for brand-name d...

Feb 10, 2025  0

Sanofi, AstraZeneca back Teva's call to rehear case on patent listings

Sanofi, AstraZeneca back Teva's call to rehear case on ...

Feb 9, 2025  0

In single case, spinal muscular atrophy pill given before birth spared baby of symptoms

In single case, spinal muscular atrophy pill given befo...

Feb 20, 2025  0